ACIN 2013: International Conference on Advanced Complex Inorganic Nanomaterials

ACIN 2013: International Conference on Advanced Complex Inorganic Nanomaterials
Event on 2013-07-15 00:00:00
Event Name: ACIN 2013: International Conference on Advanced Complex Inorganic Nanomaterials
Event Date(s): Monday, July 15, 2013 to Friday, July 19, 2013
Event Location: University of Namur (FUNDP), Auditorium Pedro Arrupe, Namur, , Belgium
Cost: 70 €- 575 €
Description: ACIN 2013 is a four day scientific meeting organised jointly by the University of Namur (FUNDP) and the Université Catholique de Louvain (UCL).

The aim of this meeting is to offer an update of recent innovations in both fundamental and applied aspects and to highlight the latest advances and progress in the field of inorganic nanomaterials (inorganics, ceramics, hybrids and bio-inspired materials).
Host Company: n/a
Contact Information: Phone: +32-81-72-54-16
Fax: +32-81-72-54-14
Email: acin2013@fundp.ac.be

at University of Namur (FUNDP), Auditorium Pedro Arrupe

Namur, Belgium

Cambridge biotech Agios Pharmaceuticals files for an IPO

Cambridge biotech Agios Pharmaceuticals files for an IPO
Agios Pharmaceuticals Inc. is the latest Massachusetts biotechnology company to explore an initial public stock offering this year. In a regulatory documents, Cambridge-based Agios said it is planning to move forward with an IPO. According to an …
Read more on Boston.com

The Best Kind of Biotech Dilution
The "d' word — dilution — gives biotech investors cold sweats at night. It can strike with little warning, leaving investors with devalued shares. Dilution is always better if avoided entirely, but it is a key source of funding for development-stage …
Read more on DailyFinance

US says unapproved biotech wheat appears limited to one field
With the U.S. wheat harvest in its early stages, the Washington State Grain Commission expressed "utmost urgency" for the USDA to spell out how it will find and isolate any biotech wheat among the tens of millions of bushels grown in the Northwest and …
Read more on Reuters

Terracon Introduces Non-Metallic Media Slurry Tank for Process-Scale Chromatography

Franklin, MA (PRWEB) June 11, 2013

Terracon Corporation has announced the introduction of a new non-metallic media slurry tank for process-scale chromatography and other biotech applications. Designed for optimal mixing of media slurry, the cylindrical cone-bottom tank is available in polyethylene or polypropylene and in sizes ranging from 200 to 2000 liters.

Terracons plastic media slurry tank eliminates the oxidization and pitting often seen with stainless tanks and the associated risk of cross contamination. According to Rob Jewett, Terracon president, this is critical to maintaining purity in the manufacturing process. Pitting, which is common when using stainless steel tanks, has the potential to compromise filtration and ultimately the production process, said Jewett. Our plastic tanks arent subject to oxidation or pitting, so theyre perfect for containment and mixing of ultrapure media.

Terracon media slurry tanks feature a vertically aligned shaft equipped with both a main turbine, which circulates the fluid in the tank, and a tickler impeller that reaches deep into the tanks cone bottom to stir up anything that may have settled. Strategically placed baffles create additional turbulence to help maintain a uniform and consistent flow of homogenous liquid throughout the tank. A rotating spray ball system is incorporated for cleaning in place (CIP) a removable lid for cleaning out of place (COP). The tanks cone shaped bottom allows for quick and complete drainage.

As with its other tank lines, Terracon molds its media slurry tanks from translucent polyethylene and polypropylene. This eliminates the need for expensive electronics sensors, transmitters, etc. commonly employed with stainless tanks to determine when they are full. End users can simply glance at the tank to gauge the level of contents.

Our new non-metallic slurry tank offers biotech and biopharma firms the performance they require at a lower cost than conventional stainless steel tanks, said Jewett. Weve raised the bar once again and delivered a solution that not only sets a new standard in terms of quality and performance, but does so while reducing production times and costs. As a company, we continue to respond to the market and offer innovative, cost-effective solutions to complex fluid management problems.

All Terracon media slurry tanks are customized to meet individual customer needs. Multiple stand options are available in various cGMP-compliant finishes and grades. The tanks are designed for use at atmospheric pressure. For further information on Terracons media slurry tanks and the companys other fluid management solutions, visit the companys website at http://www.terracon-solutions.com or contact Terracons sales group by phone at 508-429-9950 or email at sales(at)terracon-solutions(dot)com.

About Terracon Corporation:

Founded in 1976, Terracon Corporation is a leading provider of fluid management solutions to businesses in a wide range of industries, including biopharmaceutical, medical, and alternative energy. The companys customers rely on Terracon and its custom-configured products to address complex fluid containment, mixing, and processing challenges. Terracons solutions are distributed directly and through resellers, and include non-metallic tanks and vessels, mixers, and carboy rinse stations. Terracon Corporation is privately owned and based in Franklin, Massachusetts. For more information about the company, visit its website at http://www.terracon-solutions.com.







Spaulding Clinical to Showcase First Cloud-based Cardiac Safety Solution Fully Integrated with Medidata Clinical Cloud at DIA


West Bend, WI (PRWEB) June 12, 2013

“Spaulding Clinical is focused on solutions that deliver speed, unprecedented quality and lower drug development costs. The integration that we offer with Medidata Solutions delivers on this for our clients with the added-value of immediate access to 12-lead electrocardiogram (ECG) interpretations, measurements, and waveforms, in the Medidata Rave system, states Daniel Selness, General Manager and Sr. Vice President, Clinical Research for Spaulding Clinical.

Spaulding Clinical and Medidata continue to drive new levels of productivity in clinical research with cloud-based technology, first with the integration of Spauldings clinical pharmacology data with Medidata Rave, and now with the integration of their cardiac safety clinical data, states Glen de Vries, president of Medidata Solutions. Our collaboration will benefit both sponsors and CROs who are looking for innovative solutions that drive quality up and costs down.

This seamless interface demonstrates the power of interoperable systems built on open standards. Through the Medidata Rave Web Services API, Medidata has enabled Spaulding Clinical to integrate its cardiac safety solution with the Medidata platform, providing a consistent user experience, resulting in higher quality study data for sponsors, states Brock Heinz, Innovation Leader for Spaulding Clinical.

Spaulding Clinical has been recognized by Medidata Solutions as a Medidata Technology Partner since 2010, after leveraging Medidata Web Services application programming interfaces (APIs) to enable automatic study data transfer from the Spaulding Clinical Phase I EDC system to Rave. Spaulding Clinical pioneered the first fully electronic integration of Phase I study data directly into Medidata Rave, removing human data transcription errors and demonstrating significant cost and time savings.

Spaulding Clinical will be demonstrating their solutions at both the Medidata booth (#805) and Spaulding booth (#2203) at the DIA meeting, June 24-26th in Boston. Visit Spauldingclinical.com to view Spauldings quality metrics.

About Spaulding Clinical Research, LLC

Spaulding Clinical Research LLC, a change agent in the clinical research and medical device industries, is focused on driving perpetual value for its clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

Spaulding Clinical Research operates a 105-bed clinical pharmacology unit with 96, 12-lead ECG, telemetry beds in West Bend, Wisconsin, USA. The facility is paperless, using a customized Phase I Electronic Data Capture system with bi-directional interfaces to clinical lab, bedside devices and telemetry. Spaulding Biometrics provides full-service biostatistics, data management and medical writing services.

As a Phase I-IV centralized cardiac safety provider, Spaulding Clinical offers project management, expert cardiologist ECG over-read and a complete suite of state-of-the-art equipment provisioning, including the cloud-based Spaulding webECGTM Management Solution with the purpose-built Spaulding Model 1000iQ Electrocardiograph.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.







Analysis: Biotech's bull run starts to look frothy

Analysis: Biotech's bull run starts to look frothy
(Reuters) – Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the industry starts to launch …
Read more on Yahoo! News

Biotech meets DIY hacker culture, sparking new wonders and worries
Guthrie-Honea and Bergen McMurray, a biotech-savvy artist, started working on the HiveBio project several months ago. McMurray drew upon her hacker connections to find the room that will serve as HiveBio's first headquarters, inside Hackerbot Labs' …
Read more on NBCNews.com (blog)

Largest Endowment in FFA History to Impact Thousands


Washington, DC (PRWEB) June 06, 2013

A new endowment that has been established with the National FFA Foundation will allow thousands of future FFA members to attend the organizations largest leadership development conference free of charge.

Once active, the Glenn and Maggie Stith Leadership Development Fund Endowment could provide about $ 1,500 each for 110 eligible FFA members from throughout the country to attend the annual Washington Leadership Conference each year. The scholarship will be awarded to the National FFA Organization to cover the cost of each recipient to attend the conference and provide a stipend to cover travel, meals, lodging and other conference-related expenses.

Glenn Stith of Ankeny, Iowa, who grew up on a family farm in Kentucky and was an FFA member in high school, was vice president of U.S. Branded Business for Seeds, Biotech Traits and Chemistry and Global Lead of Seminis Vegetable Seeds at Monsanto for 35 years. After retiring in 2010, he was named senior associate at Context Network, a business management and strategy consulting firm providing services to global agriculture, biotechnology and food companies.

Stith and wife Maggie, a senior regional director at the National FFA Foundation, announced their gift today at the 2013 Washington Leadership Conference in Washington, D.C.

My dad told me and my two brothers that we would have to find our own way back from high school sports events. We lived 20 miles away from high school. But my dad took time away from farming to drive us to and from FFA activities, Glenn Stith said. Thats how strongly he felt about FFA and agricultural education.

To be eligible for a scholarship to attend the conference through the endowment, students must be active FFA members in good academic standing with a minimum of a 2.5 cumulative GPA. Qualifying FFA members must demonstrate financial need and be first-time attendees to the conference. Eligible FFA members who reside in Kentucky will be given first preference to receive a scholarship to attend the conference.

More than 1,800 students are registered for the 2013 Washington Leadership Conference, the second-largest student experience that the National FFA Organization hosts each year. From June 4-July 21, FFA members will spend a week under the guidance of educational professionals, counselors and professional FFA staff members. In workshops, seminars and small groups, students will focus on identifying and developing their personal strengths and goals and undergo comprehensive leadership training that will help them guide their local FFA chapters.

Students will also analyze needs of their communities back home, develop a wide-ranging and high-impact community-service initiative and implement their plan with the help of their FFA chapter upon return home. Students in recent years have created food and clothing drives, volunteer campaigns, educational outreach initiatives and more.

“Glenn and Maggies generosity will make it possible for thousands of FFA members to attend the Washington Leadership Conference for years to come,” said National FFA Organization CEO Dr. Dwight Armstrong. Their generosity focuses on one of our core values, which is living to serve. Giving back and helping future generations has always been a driving force in Glenn Stiths personal and professional life. He and Maggie encourage others to contemplate how they can make a difference in the lives of others through dedication and support.

Since being an FFA member, earning a bachelors degree in agriculture economics from the University of Kentucky and an executive masters degree from Washington University, Stith has made giving back to FFA a top priority, including stints serving as chair of the foundations Sponsors Board and on the board of trustees. He became a member of the foundations Individual Giving Council last year and will assume chair of the group later this year.

The most satisfying thing I can do is give back and help young people achieve their dreams and have an opportunity to enjoy a wonderful career like Ive had, he said. I take a great deal of pleasure in contributing. There is no greater satisfaction than being able to give back to a good cause like FFA.

The National FFA Foundation is the fundraising arm of the National FFA Organization, which provides leadership, personal growth and career success training through agricultural education to 557,318 student members in grades seven through 12 who belong to one of 7,498 local FFA chapters throughout the U.S., Puerto Rico and the Virgin Islands.







Vanda Pharmaceuticals: A Small-Cap Biotech With A Pipeline Allowing For Long

Vanda Pharmaceuticals: A Small-Cap Biotech With A Pipeline Allowing For Long
Vanda Pharmaceuticals (VNDA) has a very promising pipeline, which will help long-term oriented investors. Vanda has a pipeline that will set it up for success, as well as some very promising drugs. There are a mix of medium and long-term catalysts that …
Read more on Seeking Alpha

Omnipress Exhibits at the 2013 Society of Pharmaceutical and Biotech Trainers
Omnipress, provider of educational content solutions for associations, will attend the 2013 Society of Pharmaceutical and Biotech Trainers (SPBT) Annual Conference in Orlando, Florida, June 10-13, 2013. Omnipress will be promoting their blended …
Read more on PR Web (press release)

Owego biotech firm cited for innovation
John M. Baust, president and lead scientist of CPSI Biotech, was presented with the award on May 16 at a ceremony in Washington, D.C. “It serves as a recognition by the SBIR program that we are doing some neat and translatable research,” Baust said …
Read more on Press & Sun-Bulletin